Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Coeptis Therapeutics Hldgs Inc (COEP)

Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Coeptis Therapeutics Hldgs Inc 105 BRADFORD ROAD SUITE 420 WEXFORD PA 15090 USA

https://coeptistx.com Employees: 7 P: 724-934-6467

Description:

Coeptis Therapeutics Holdings Inc., together with its subsidiaries including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals Inc., is a biopharmaceutical company developing innovative cell therapy platforms for cancer. Coeptis Therapeutics Holdings Inc., formerly known as Bull Horn Holdings Corp., is based in WEXFORD, Pa.

Key Statistics

Overview:

Market Capitalization, $K 5,818
Enterprise Value, $K 4,498
Shares Outstanding, K 41,119
Annual Sales, $ 0 K
Annual Net Income, $ -21,270 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,830 K
EBIT, $ -660 K
EBITDA, $ 340 K
60-Month Beta -0.90
% of Insider Shareholders 24.25%
% of Institutional Shareholders 13.88%
Float, K 31,148
% Float 75.75%
Short Volume Ratio 0.26

Growth:

1-Year Return -83.72%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 11/13/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -0.29
EPS Growth vs. Prev Qtr 37.50%
EPS Growth vs. Prev Year 82.76%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

COEP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,094.50%
Return-on-Assets % -219.97%
Profit Margin % 0.00%
Debt/Equity 0.03
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.16
Book Value/Share 0.12
Interest Coverage -192.36
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar